Skip to main content
. 2021 Oct 29;12:775506. doi: 10.3389/fphar.2021.775506

FIGURE 2.

FIGURE 2

KU-19–19 and RT4 were treated with erianin in combination with or without other cell death inhibitors Nec-1, DFO, Z-VAD and CQ for 24 h, then cell viability was assayed. *p < 0.05.